Work

Analysis of the immunological biomarkers CD20 and T-bet in invasive and non-invasive urothelial bladder cancer tissue

Year: 2025
Type: dissertation
Study design: Observational Study
Abstract: Urothelial bladder cancer is one of the most common cancers and a major global health challenge. In the development of cancer, the tumor immune microenvironment (TIME) plays a central role. Within TIME, B cells and T cells are key components of the adaptive immune system, and immune cell infiltration has been associated with treatment response and prognosis. To localize B cells and T cells in tumor tissue, immunological markers such as CD20 and T-bet are commonly used. However, the expression patterns of these markers in urothelial bladder cancer tumors remain incompletely characterized. The aim of this study was to investigate whether the presence of CD20⁺ B cells and T-bet⁺ T cells differ between non–muscle-invasive papillary bladder cancer (NMIBC papillary), non–muscle-invasive flat bladder cancer (NMIBC flat), and muscle-invasive bladder cancer (MIBC), and whether a correlation exists between the expression levels of these markers within each tumor type. Immunohistochemical staining for CD20 and T-bet was performed on tissue microarrays (TMA) from 238 patients with urothelial bladder cancer. Cell counts per mm² were manually quantified and compared between tumor tissue groups. Biomarker expressions were also examined in relation to clinical parameters including sex, age, smoking status, recurrence, and BMI. Furthermore, tertiary lymphoid structures (TLS) were analyzed in relation to both tumor groups and biomarker densities. Statistical analyses included Kruskal–Wallis tests, Mann–Whitney U tests, and Spearman’s correlation. The density of CD20⁺ B cells and T-bet⁺ T cells was significantly lower in NMIBC papillary compared to both NMIBC flat and MIBC, while no difference was observed between NMIBC flat and MIBC. A positive correlation between CD20⁺ B cell and T-bet⁺ T cell density was observed in NMIBC flat and MIBC, but not in NMIBC papillary. No significant differences in cell density were found in relation to sex, age, BMI, or smoking status. However, across all tumor types, T-bet⁺ T cell density was significantly higher in tumors from patients who remained recurrence-free compared to those who later developed recurrence. No significant differences in TLS counts were found between tumor groups, but a weak negative correlation with T-bet⁺ t cell density was observed. As a conclusion, the observed differences in immune cell infiltration between tumor subtypes may reflect underlying variations in tumor immunobiology. Among the analyzed markers, T-bet density in tumor tissue from diagnostic biopsies was associated with recurrence risk after treatment, suggesting potential prognostic value. However, the impact of post-diagnostic treatment was not accounted for, and therefore the findings should be interpreted with caution.
Author: Norén Almén, Adrian
Institution: Karlstad University
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: green
OpenAlex ID: W7054406818
Cites: 30
Cited by:
Related to: 10